Physician profile
Reuben C Lufrano
NPI 1649699398
$3,764.86
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $550 · 2021: $444 · 2022: $812 · 2023: $291 · 2024: $1,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,097 · Food and Beverage: $604 · Education: $36.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,096.50 |
| Food and Beverage | $604.12 |
| Education | $36.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,910.47 | 2020-2024 | Gamma, Pro, Mako |
| Smith+Nephew, INC. | $402.15 | 2020-2022 | |
| Globus Medical, INC. | $168.31 | 2022-2023 | A/R Femoral Nail |
| Acell, INC. | $148.48 | 2019 | |
| Depuy Synthes Sales INC. | $121.93 | 2019-2023 | Na, Tfn-Advance |
| Innovation Technologies INC | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reuben Lufrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.